RAPH   $1.0  -40.12% Market Closed

Raphael Pharmaceutical Inc
Total Cash 120.00K
totalCashPerShare 0.006
EBITDA
Total Debt 0.00
quickRatio 0.287
currentRatio 0.301
Total Revenue
debtToEquity
Revenue/Share
ROA -7.03947
ROE
grossProfits
freeCashflow -570.38K
operatingCashflow -979.00K
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 4.74M
forwardPE
floatShares 10.35M
sharesOutstanding 18.79M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.51%
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.016
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -1.40M
trailingEps -0.07%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Nov. 1, 2024, 10:17 p.m.